UNIVERSAL HEALTH SERVICES INC UHS
NYSE Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026
Market cap
$12.52B
P/E (GAAP, TTM)
8.14
P/E (operating)
8.20
Dividend yield
0.4%
Revenue growth YoY
5.3%
EPS growth YoY
-10.9%
ROIC
12.9%
Piotroski F-score
7
Three ways to read the P/E
P/E (GAAP, TTM)
8.14
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
8.41
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
8.20
After-tax operating income only: the core business.
P/E (excl. gains)
8.84
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | Year ago | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | 8.3% | 9.6% | -1.4 pts | — | — |
| EPS growth YoY (qtr) | 10.1% | 17.7% | -7.6 pts | — | — |
| Revenue growth (TTM) | 10.0% | 10.4% | -0.4 pts | — | — |
| EPS growth (TTM) | 29.2% | 34.6% | -5.4 pts | — | — |
| P/E (GAAP, TTM) | 7.12 | 6.21 | +0.90 | — | — |
| P/E (operating) | 7.35 | 6.28 | +1.08 | — | — |
| P/E (excl. gains) | 7.93 | 6.76 | +1.16 | — | — |
| P/B | 1.54 | 1.32 | +0.23 | — | — |
| ROIC | 12.9% | 12.9% | 0.0 pts | — | — |
| Net margin | 8.6% | 8.6% | 0.0 pts | — | — |
| Dividend yield | 0.5% | 0.5% | -0.1 pts | — | — |
| EPS (TTM) | 24.50 | 23.95 | +2.3% | — | — |
| Price | $174.32 | $148.74 | +17.2% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $4.73B | 2.1% | 5.3% | 5.22 | -12.7% | -10.9% | 6.5% |
| Jun 30, 2026 | $4.64B | 3.2% | 8.3% | 5.98 | 5.8% | 10.1% | 7.7% |
| Mar 31, 2026 | $4.50B | 0.2% | 9.6% | 5.65 | -19.4% | 17.7% | 7.8% |
| Dec 31, 2025 * | $4.49B | -0.2% | 9.1% | 7.01 | 19.6% | 41.9% | 9.9% |
| Sep 30, 2025 | $4.50B | 4.9% | 13.4% | 5.86 | 7.9% | 54.2% | 8.3% |
| Jun 30, 2025 | $4.28B | 4.5% | 9.6% | 5.43 | 13.1% | 27.5% | 8.2% |
| Mar 31, 2025 | $4.10B | -0.3% | 6.7% | 4.80 | -2.8% | 25.7% | 7.7% |
| Dec 31, 2024 * | $4.11B | 3.8% | 11.1% | 4.94 | 30.0% | 57.8% | 8.1% |
| Sep 30, 2024 | $3.96B | 1.4% | 11.2% | 3.80 | -10.8% | 58.3% | 6.5% |
| Jun 30, 2024 | $3.91B | 1.7% | 10.1% | 4.26 | 11.5% | 76.0% | 7.4% |
| Mar 31, 2024 | $3.84B | 3.8% | 10.8% | 3.82 | 22.0% | 67.5% | 6.8% |
| Dec 31, 2023 * | $3.70B | 4.0% | 7.4% | 3.13 | 30.4% | 29.3% | 5.8% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 13, 2026 | Date of the latest closing price used. |
| Price | $194.28 | Latest closing price. |
| Market cap | $12.52B | Price × shares outstanding. |
| Enterprise value | $17.14B | Market cap + debt − cash: the price of the whole business. |
| Shares | 64.46M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | 8.41 | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | 8.14 | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | 8.20 | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | 8.21 | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | 8.84 | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | 0.23 | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | 0.61 | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | 11.9% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | 12.3% | TTM EPS ÷ price. |
| P/B | 1.72 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 0.72 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 0.68 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | 14.75 | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | 6.56 | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | 8.59 | Enterprise value ÷ operating income. |
| EV/Sales | 0.99 | Enterprise value ÷ revenue. |
| Book value / share | 112.87 | Shareholders' equity ÷ shares. |
| FCF yield | 6.8% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | 23.70 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | $93.29M | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | — | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | -$21.87M | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 4.8% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Sep 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $4.73B | Revenue of the latest reported quarter. |
| Net income (qtr) | $308.68M | Net income of the latest reported quarter. |
| EPS (qtr) | 5.22 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | 5.3% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | 2.1% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | -10.9% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | -12.7% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | -17.2% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | -13.9% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | — | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | 9.6% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | 6.5% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $18.35B | Revenue of the last four quarters. |
| Net income (TTM) | $1.46B | Net income of the last four quarters. |
| EPS (TTM) | 23.86 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 8.0% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 13.5% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 6.3% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.4% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | $0.8000 | Dividends per share paid over the last 12 months. |
| Payout ratio | 3.5% | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | 6.0% | Dividends ÷ free cash flow. |
| Dividend growth (1y) | 0.0% | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | 0.0% | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | 5.9% | Annualised dividend growth over 5 years. |
| Payments (12m) | 4 | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | Sep 1, 2026 | Most recent ex-dividend date. |
| Buyback yield | 7.7% | Share repurchases ÷ market cap. |
| Shareholder yield | 8.1% | Dividend yield + buyback yield. |
Profitability
| Gross margin | — | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | 15.0% | EBITDA ÷ revenue. |
| Operating margin | 11.5% | Operating income ÷ revenue. |
| Net margin | 8.6% | Net income ÷ revenue. |
| FCF margin | 4.9% | Free cash flow ÷ revenue. |
| ROE | 20.5% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | 9.6% | Return on assets: net income ÷ total assets. |
| ROIC | 12.9% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | 9.7% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | 30.4% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | 37.3% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | 9.0% | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | 36.2% | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 1.05 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 1.05 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 0.04 | Cash ÷ current liabilities. |
| Debt / equity | 0.65 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.31 | Total debt ÷ total assets. |
| Debt / EBITDA | 1.82 | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | 1.77 | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | 12.78 | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | 57.0% | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | -2.4% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 0.6% | Share-based compensation ÷ revenue. |
| R&D % revenue | — | Research & development spending ÷ revenue. |
| SG&A % revenue | — | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 23.4% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 1.12 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | 55 | Average days to collect payment from customers. |
| Days inventory | — | Average days inventory is held. |
| Days payables | — | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $246.33 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $138.06 | Lowest price in the last 52 weeks. |
| From 52-week high | -21.1% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 40.7% | How far above the 52-week low the price is. |
| Avg volume (30d) | 364.33K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $67.49M | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 7 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 3.19 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $17.36B | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | $1.49B | Net income of the latest fiscal year. |
| Diluted EPS | 23.10 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | $2.61B | Operating income + depreciation & amortization. |
| Free cash flow | $849.25M | Operating cash flow − capital spending. |
| Total debt | $4.75B | Long-term plus current debt. |
| Cash | $137.80M | Cash and equivalents. |
| Equity | $7.28B | Shareholders' equity. |
| Total assets | $15.53B | Total assets. |